Project Grant R61AI187095
Award Date
12/13/24
Completion Date
11/30/27
Dollars Obligated
$427K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $431,143 to Tufts University School of Medicine to develop methods for continuous in vitro propagation of the parasite Babesia microti. The goal is to enable new drug development and improve understanding of the biology of this parasite, which has led to increased human babesiosis cases in the Northeastern United...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the structural, morphological, rheological, and functional changes that occur in red blood cells (RBCs) infected by the Babesia parasite, the causative agent of babesiosis. The overarching goal is to identify the key Babesia proteins, including proteases, that interact with and alter the host...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $874,372 to Yale University to conduct research on parasite-derived vesicles in Babesia virulence and vaccine development. The research aims to elucidate the molecular mechanisms by which Babesia species communicate with their host and leverage this knowledge to engineer an effective and safe vaccine for...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $187,056 to The Children's Hospital of Philadelphia (CHOP) over a 5-year period ending June 30, 2030. The grant supports research aimed at determining the role of erythrocyte (red blood cell) glycolysis, a key metabolic pathway, in the lifecycle of the malaria parasite Plasmodium falciparum. The research objectives are...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $392,710 to the University of Georgia Research Foundation, Inc. to establish continuous, high-yield culture systems for the malaria parasite Plasmodium vivax (P. vivax). The primary objectives are to (1) develop P. vivax strains that can robustly invade reticulocytes in culture and (2) improve P. vivax development in...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $250,573.00 to the University of Pittsburgh to conduct research on the impact of host genetic polymorphisms on Babesia microti (B. microti) infection transmitted by ticks. The key objectives are to: Test the hypothesis that host genetic factors significantly impact tick-transmitted B. microti infection, including...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $267,168 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Institut Pasteur DU Cambodge, a non-profit research establishment in Phnom Penh, Cambodia. The grant aims to leverage access to Plasmodium vivax (P. vivax) parasite diversity to identify culture-adaptable strains and develop robust in vitro culture systems. This would enable advanced studies on P. vivax malaria, which poses...
The Project Grant award R01AI187153 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on identifying genetic factors associated with sexual stage development (gametocyte formation) in the malaria parasite Plasmodium falciparum. The $700,288 award, with a project period from Nov 2024 to Oct 2029, will fund a research project at the University of South Florida to perform...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $520,809 in funding to Rosalind Franklin University of Medicine & Science over the period from September 5, 2024 to August 31, 2029. The overarching goal of this research project is to investigate the role of TAM receptors in modulating the humoral immune response against parasitic infections, such as malaria....